Study of FP-1039 in Subjects With Endometrial Cancers
This study has been withdrawn prior to enrollment.
(Study FP1039-002 was not feasible. The original assumption was at least 5% of patients screened would qualify, but after screening 70 patients, none qualified.)
Sponsor:
Five Prime Therapeutics, Inc.
Collaborator:
Worldwide Clinical Trials, LLC, St. Petersburg, Russia
Information provided by (Responsible Party):
Five Prime Therapeutics, Inc.
ClinicalTrials.gov Identifier:
NCT01244438
First received: November 17, 2010
Last updated: March 8, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Study Status: | This study has been withdrawn prior to enrollment. |
|---|---|
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |